LC determination of carbamazepine in murine brain
- 17 August 2001
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 26 (4) , 573-577
- https://doi.org/10.1016/s0731-7085(01)00477-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) miceBritish Journal of Pharmacology, 1999
- Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind studyThe Lancet, 1999
- Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsProceedings of the National Academy of Sciences, 1997
- High-speed liquid chromatographic method for the monitoring of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- MDR1 Gene Expression in Brain of Patients with Medically Intractable EpilepsyEpilepsia, 1995
- Narrow-bore liquid chromatographic assay for oxcarbazepine and its major metabolite in rat brain, liver and blood microdialysatesJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Analysis of carbamazepine in serum by liquid chromatography with direct sample injection and surfactant-containing eluentsJournal of Chromatography A, 1990
- Sensitive Analysis of Antiepileptic Drugs in Very Small Portions of Human Brain by Microbore HPLCJournal of Liquid Chromatography, 1987
- Simultaneous Determination of Ethosuximide, Phenobarbital, Pheny-Toin, and Carbamazepine in Brain Tissue by HPLCJournal of Liquid Chromatography, 1985